www.fdanews.com/articles/159289-china-updates-penalty-inspection-regs-in-wake-of-pharma-industry-probe
China Updates Penalty, Inspection Regs in Wake of Pharma Industry Probe
October 18, 2013
The China Food and Drug Administration is asking the public to comment on proposed revisions to its regulations and penalties related to inspections and investigations, an apparent response to the ongoing bribery scandal that has rocked the pharmaceutical industry.
International Pharmaceutical Regulatory Monitor
International Pharmaceutical Regulatory Monitor